Navigation Links
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
Date:11/1/2011

TUESDAY, Nov. 1 (HealthDay News) -- Age in itself should not be a factor in deciding whether blood cancer patients are candidates for stem cell transplantation, according to a new study.

Blood cancers include leukemia, lymphoma and myeloma.

For the study, researchers analyzed long-term outcomes among 372 blood cancer patients aged 60 to 75 who underwent a "mini-transplant," which is a "kinder, gentler" form of allogeneic (cells from another person) stem cell transplantation developed at the Fred Hutchinson Cancer Research Center in Seattle.

The five-year rates of overall survival and disease progression-free survival among the patients were 35 percent and 32 percent, respectively. Comparable survival rates were seen when the patients were divided into three age groups -- 60 to 64, 65 to 69, and 70 to 75 -- suggesting that age plays a limited role in the success of the mini-transplant.

While a survival rate of one-third may seem low, all of the patients would have died within months if they didn't have the transplant, Dr. Mohamed Sorror, an assistant member of the Hutchinson Center's Clinical Research Division, noted in a news release from the Center.

The investigators also found that greater cancer aggressiveness and having a larger number of medical problems not linked to cancer ("comorbidities") were two factors that affected survival, regardless of age.

For example, the five-year survival for patients with less aggressive cancer and fewer comorbidities was 69 percent, compared with 23 percent for patients with more aggressive cancer and a large number of comorbidities, according to the report in the Nov. 2 issue of the Journal of the American Medical Association.

Conventional stem cell transplants are generally not performed on blood cancer patients older than 60 because high doses of total-body radiation and potent chemotherapy are used to prepare patients for transplantation.

However, the mini-transplant relies on the donor's immune cells to kill the cancer, and low-dose radiation and chemotherapy is used to suppress the immune system rather than destroy it.

More information

The U.S. Centers for Disease Control and Prevention has more about blood cancers.

-- Robert Preidt

SOURCE: Fred Hutchinson Cancer Research Center, news release, Nov. 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dementia Rates Escalate as Brain Capacity Diminishes with Age
2. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
3. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
4. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
5. Rate Regulation for Health Insurance: Obama Administration Should Look to CAs Model Law Which Has Saved Drivers $62 Billion Since 1988
6. CareTech Solutions Showcases Web Portal for Hospital Boards and Administrators at HIMSS10
7. National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics
8. Adverse events rate is low when propofol is administered by trained professional
9. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
10. New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid
11. The Power of Prayer Deterred Tsunami's Destruction Ministry Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
(Date:2/11/2016)... ... February 11, 2016 , ... ... trainer and author Ray Clarke poses a question as a challenge for his ... his book, "Being in the Being" (published by Partridge Singapore), Clarke explores the ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. announces the Infusion ... of Practice, to include vascular visualization as a standard practice. AccuVein ( http://www.accuvein.com ... the market, facilitates adherence to this standard with its easy to use, widely ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pixel Film Studios brings ... with customizable backdrops in the Christmas edition of the ProDrop series. Pick and choose ... audiences and invoke the spirit of Christmas using ProDrop's wintry generators. ProDrop Christmas is ...
(Date:2/11/2016)... ... 11, 2016 , ... Food Labeling for American Heart Month ... best practices in the past couple of decades, and food manufacturers and distributors ... which acts as an exceptional opportunity to revise food labels and stickers to ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... (WMIS), known as the World Molecular Imaging Congress (WMIC), will be held in ... the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Iowa , Feb. 11, 2016  Proliant Biologicals ... Zealand Bovine Serum Albumin (BSA) manufacturing facility.  The facility ... New Zealand , in Feilding. ... was done to functionally duplicate the systems in the ... same vendors used for U.S. installations.  --> ...
(Date:2/11/2016)... , Feb. 11, 2016  Attending college is ... those with type 1 diabetes, the journey can be ... schedules, assignments and campus activities, they also manage the ... top of that, many are living away from home ... (Foundation) Lilly Diabetes Tomorrow,s Leaders Scholarship with $100,000 ...
(Date:2/11/2016)... Brain Cancer patients in the Mid-South now ... Cancer Center . Optune™, a portable device ... replication causing death of cancer cells, is the first ... a significant extension in overall survival rates for newly ... Center is the only medical center in ...
Breaking Medicine Technology: